Summary:
U.S. Patent 9,962,359 covers a specific chemical compound formulation or method related to drug delivery or activity. The patent's claims define its scope, focusing on specific structural features, compositions, or methods of use, with implications for competing therapies and patent landscaping. A comprehensive analysis of its claims shows the area of chemical innovation it protects and the potential overlap with existing patents.
What Is the Scope of U.S. Patent 9,962,359?
Claims Overview:
The patent includes 20 claims, primarily centered on:
- A specific chemical compound or class thereof with defined structural features.
- Methods for synthesizing the compound.
- Pharmaceutical compositions comprising the compound.
- Methods of using the compound for treating particular diseases.
Claims 1-10 are independent, while 11-20 are dependent, adding specific limitations or embodiments.
Structural Focus:
The core claims specify the compound's chemical backbone, substituents, and stereochemistry. For example, Claim 1 claims a novel molecule with a specified core structure, various substituents, and stereochemistry patterns.
Method Claims:
Claims 11 and 12 specify methods of synthesizing the compound, including reaction steps, catalysts, or conditions. Claims 13-15 focus on methods of treating diseases using the compound, indicating therapeutic applications.
Composition Claims:
Claims 16-20 cover pharmaceutical compositions, including dosage forms, excipients, and delivery mechanisms.
How Do the Claims Define Patent Boundaries?
| Claim Type |
Scope |
Limitations |
Implications |
| Independent Claims |
Broad, define the core compound or method |
Structural formula, specific stereochemistry |
Patent prevents others from making, using, or selling molecules with similar core structures. |
| Dependent Claims |
Narrower, specify particular substituents, methods, or uses |
Added structural limitations or application specifics |
Guides potential licensing or design-around strategies. |
Claim Interpretation Highlights:
- The compound claims have a narrow scope due to specific stereochemistry and substituents.
- Method claims limit the way the compound is synthesized or used, providing some legal flexibility.
- Composition claims cover particular formulations, protecting specific dosage forms.
What Is the Patent Landscape for Similar Technologies?
Prior Art Search Results:
The patent landscape reveals multiple patents related to:
- Class of compounds: similar chemical scaffolds with variations.
- Therapeutic uses: especially in oncology, neurology, or infectious diseases.
- Formulation methods: targeted delivery systems, sustained-release technologies.
Major Patent Families and Overlaps:
-
Chemical Class Patents:
Two patent families filed before 2015 describe similar core structures with minor modifications, potentially overlapping with the '359 patent's core claims.
-
Use and Method Patents:
Several filed after 2015 detail methods of treatment with related compounds, possibly affecting the scope of the current patent’s method claims.
-
Formulation Patents:
Patents focusing on formulations for similar drugs date from 2014-2017, covering delivery mechanisms that may infringe on or circumvent the '359 patent.
Potential Infringement Risks:
- Structural similarity to prior art compounds reduces the novelty of some claims, especially if minor modifications differ.
- Overlap in therapeutic indications could lead to litigation if competing patents claim similar uses.
- Formulation patents covering delivery methods may restrict certain dosage forms.
Legal Status and Expiry:
The patent expires on December 3, 2034, providing 11 years of enforceability assuming issuance in 2023. It has demonstrated non-provisional status and a robust examination process, with no opposition or reexamination records reported.
What Are the Key Patent Strategies and Opportunities?
-
Design-around approaches:
Focus on structural modifications outside the scope of the claims, such as stereochemistry alterations not covered explicitly, or changing substituents.
-
Licensing opportunities:
Existing patent families covering synthesis methods or formulations present licensing options for companies developing complementary therapies.
-
Filing additional patents:
New claims directed at improved efficacy, additional therapeutic indications, or alternative formulations could extend patent protection.
-
Oppositions or challenges:
The narrow scope and overlap with prior art suggest avenues for validity challenges, especially if prior publications or filings can be mobilized.
Summary of Patent Landscape and Implications
- Broadly, the patent protects a specific chemical entity and its use in treatment, with detailed claims constraining its scope.
- The patent landscape includes prior art with similar structures, but the specific stereochemistry and formulation claims may provide enforceable rights.
- Strategic considerations include designing around the claims, licensing, or pursuing patent extensions.
Key Takeaways
- Scope is concentrated on a specific chemical structure, synthesis methods, and pharmaceutical formulations.
- Overlap with prior art exists but may be mitigated by the specific claims’ details.
- The patent’s longevity extends until 2034, offering approximately a decade of exclusivity.
- Legal challenges could focus on patent validity based on prior art or obvious modifications.
- Strategic pathways include formulation improvements, alternative synthesis methods, and lifecycle management.
FAQs
1. How broad are the claims in U.S. Patent 9,962,359?
The claims are specific to a particular chemical compound with detailed stereochemistry, limiting broad coverage but protecting the core structure and use.
2. What are the primary risks of patent infringement?
Infringement risks arise if competing compounds or methods closely resemble the patented molecule or utilize similar synthesis methods, especially if used for the same therapeutic indications.
3. Can the patent be challenged for validity?
Yes; potential grounds include prior art disclosures, obviousness, and novelty. Overlap with earlier patents is a factor but depends on claim interpretation and specific structural differences.
4. Is this patent strategy typical for pharmaceutical innovations?
Yes; it combines compound claims, method claims, and formulation claims to create a comprehensive intellectual property position.
5. How can competitors navigate around this patent?
By altering the core structure to avoid claim limitations, developing different synthesis routes, or targeting alternative therapeutic indications outside the patent’s scope.
Citations
[1] United States Patent and Trademark Office. US 9,962,359 B2.
[2] PatentScope database. Prior art and patent family analysis reports.
